STING1 and neoplasm: CD103, marking tumor-reactive T cells, shows additional prognostic value, especially in patients with advanced disease undergoing radiotherapy, where high CD103+ T cell infiltration combined with elevated STING levels associates with better disease-free and disease-specific survival.